Post Profile






See more about: PTC Therapeutics

Related Posts


Sarepta Therapeutics Inc (SRPT), PTC Therapeutics, Inc. (PTCT) and More: Here’s Why These Stocks Are on Investors’ Radars Today

PTC Therapeutics Initiates Two Clinical Trials Of PTC299 In Cancer Patients

Health : Medical News Today

PTC Therapeutics, Inc. (PTC) announced the initiation of two clinical trials of the company's product candidate PTC299 in adult patients with solid tumor cancers and Kaposi Sarcoma, a HIV-related cancer. PTC299 is an orally delivere...

PTC Therapeutics Completes Enrollment Of Pivotal Trial In Muscular Dystrophy

Health : Medical News Today

PTC Therapeutics, Inc. (PTC) announced that it has successfully completed patient enrollment of its pivotal clinical trial of PTC124 in patients with nonsense mutation Duchenne and Becker muscular dystrophy (nmDMD/BMD). Accrual was ...

PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function In Patients With Duchenne Muscular Dystrophy

Health : Medical News Today

PTC Therapeutics, Inc. (PTC) announced promising findings in patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) at the 13th International World Muscle Society (WMS) Congress.

PTC Therapeutics Initiates Phase 2 Clinical Trial Of PTC299 In Patients With Neurofibromatosis Type 2

Health : Medical News Today

PTC Therapeutics, Inc. (PTC) announced the initiation of a Phase 2 clinical trial of PTC299 in adult patients with neurofibromatosis type 2 (NF2), a rare genetic disorder that causes the development of non-malignant brain tumors. PT...

Comments


Copyright © 2016 Regator, LLC